Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice

Figure 4

PWE with only focal-onset seizures at baseline: responder rate, seizure freedom rate, and percentages of PWE with unchanged or worsening seizure frequency (relative to baseline) at month 3, month 6, month 12, and the last visit. Response was defined as ≥50% seizure frequency reduction from baseline. Seizure freedom was defined as no seizures since at least the prior visit; therefore, seizure freedom rates at month 3, month 6, and the last visit represent the percentages of PWE who had no seizures for ≥3 months, and the seizure freedom rate at month 12 represents the percentage of PWE who had no seizures for ≥6 months. PWE: people with epilepsy.